Site of exit – Talk Bio

Actionable Insights Powered by AI

AstraZeneca Ends Manufacturing License at Indian Plant and Exits Site as Part of Global Strategy

AstraZeneca; India; manufacturing license; site exit; Bangalore plant; contract manufacturing; global strategy; pharmaceutical industry